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In the past decade significant advances have been made in
our ability to assess noninvasively regional myocardial blood
flow utilizing radionuclide imaging techniques
. Conventional
single photon myocardial perfusion imaging approaches with
a gat:ima scintillation camera using either planar or SPECT
methodology and tracers such as thallium-201 or technetium-
99m isonttriles permit evaluation of only relative alterations
in regional flow under stress conditions or at rest . Absolute
quatimdon of flow in mllmin per g has not been accom-
plished .
The present study. In this issue of the Journal, Nienaber
et al . (II describe a method far quamitation of regional
myocardial blood flow after intravenous injection of nitro-
gen-13 (N-13) ammonia and rapid sequential imaging by
dynamic positron emission tomography (PET). PET imaging
permits tomographic reconstruction that reflects radietracer
concentrations in the heart relatively unaffected by tissue
attenuation (2) . N-13 ammonia (half-life 10 min) is cyclotron-
produced aid after intravenous injection is extracted by the
myocardium and metabolically trapped by the gtutamine
synthetase reaction producing N-13-labeled gtutamine (3-7),
Retention half-times of the N-13 atom in the myocardium
range from 60 to 120 min, which is sufficient for acquisition
of high quality tomographic images of the heart . Clinical
imaging of relative myocardial blood flow with this tracer has
successfully been accomplished employing exercise or phar-
macologic stress (8,9). The capability and usefulness of PET
with N-13 ammonia to quantitate absolute flow under stress
conditions in the clinical setting has not yet been clearly
demonstrated .
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(10 .11) and in the current report by Nienaber et al . (1) is an
important contribution in making progress toward clinical
quantitative PET imaging. The main feature of this work is
that tracer kinetic principles have been applied to develop
quantitative measurements of regional flow . This is accom-
plished using an arterial sample to obtain an input function
that is then combined with data from high temporal myocar-
dial sampling to compute the index of myocardial blood flow .
Two features of this approach are notable . First is the
sampling of the arterial input function . After intravenous
injection of any tracer, spreading of the tracer bolus, which
occurs before it reaches the coronary artery, will affect the
shape of the indicator-dilution curve sampled within the
capillary bed so that sampling the myocardial tracer concen-
tradon alone will not yield an accurate indication of regional
myocardial flow. Nienaber et al . (l) use a simple but appar-
ently adequate method to correct upstream bolus spreading .
Concentrations of N-13 activity in blood were derived from
a small region of interest located in the center of the left
ventricular blood pool.
A second narabtefeaatre oftllis work is the recognition of
nonliner tracer extracrion as a funrifan of blood flaw. The
extraction of N-I3 ammonia is observed to follow the model
of
Renkin and Crone, which predicts an exponential relation
between blood now and tracer extrctfun . This model pre-
dicts progressively lower tracer extraction across a capillary
membrane as the flow velocity through the capillary be-
comes greater. The regression equation inherent in the
model permits direct conversion of observed net extractions
of N- 13 ammonia to blood flow, which compensates for the
flow-dependenl decrease in net extraction . The model is a
general one that should apply to single photon tracers such
as thallium-201 and the new technetium-99m perfusion
agents, as well as to ammonia . Recognition and correction of
the effect of flow dependency an extraction is necessary
before tracer uptake can be accurately related to myocardial
blood flow over a wide flow range using any extractable
tracer .
Clinical appltcabilly . Does this work presage general
clinical utilization of PET? Although PET offers unique
clinical capability, in this era of cost containment it is
perhaps difficult to predict rapid growth of such a complex
and expensive technology . It seems more likely that for the
time being PET will continue as a primarily investigative
tool . The study by Nienaber et al. (1) is a good example of
methodology developed for PET, which can influence simi-
lar developments with other imaging modalities. For exam-
ple, digital fluoroscopy oilers the potential to perform similar
indicator dilution analyses . To similarly quantify myocardial
blood flow might require the development of extractable
contrast agents but the PET work could demonstrate the
utility of such development. Contrast agents (microbubbles)
used with eehocardiography have been detected in left
ventricular myocardium after intravenous injection and sim-
ilar methods could be used for analysis of contrast echo
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indicator-dilution data . Magnetic resonance imaging is now
capable of detecting indicators in large vessels and myocar-
dium using flash reconstruction techniques . Single photon
radionuclide indicators offer similar possibilities than could
become three-dimensional with the development of
rapid
SPECT
imaging . Compared With
PET, these
alternatives
offer formidable challenges and would require more devel-
opment to be useful. However, an important role for PET
may be to lead the way toward such advances .
To
what extent will improved quantitative regional myo-
cardial bloodflow imaging be clinically useful? The amount
of effort to be expended on developing regional myocardial
flow quantitation might well depend on the clinical impor-
tance of having this capability. Will enhanced blood flow
quantitation lead to improved detection of physiologically
relevant coronary artery stenoses in patients with underlying
coronary artery disease? Recent data
(12,13) using PET and
rubidium-82 for semiquantitative assessment of blood flow
after dipyridamole stress are encouraging in this regard.
However, it is still not clear whether stenoses detection rates
utilizing PET
methodology will be greatly superior to care-
fully performed quantitative single photon planar or SPECT
imaging of regional myocardial perfusion . Will improved
blood flow determination with corresponding regional myo-
cardial metabolism measurements with PET prove to be the
ultimate in vivo "gold standard - of myocardial viability?
Significant progress has indeed been made in imaging of
myocardial metabolism with PET
employing fluorine-IS
2-deoxyglaense (14,15) and C-11
acetate (16). Thus, the
work from research centers with
PET capability will be of
utmost importance in seeking answers to such questions
regarding the clinical applicability of quantitative myocardial
blood flow imaging .
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